STAT+: Early update shows Wave’s RNA drug cut visceral fat
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! With STAT reporting from ASH this year, we have some stories in the blood space. Also, a potential Dupixent competitor is in the works, and we examine the fallout from Friday’s ACIP meeting. […]
Is addiction the next frontier for GLP-1 receptor agonists?
GLP-1 drugs failed to slow Alzheimer’s in two big clinical trials
Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, researchers aren’t giving up yet.
Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump
Quick Read Abbott Laboratories (ABT) grew revenue 6.9% with medical devices up 14.8% to $5.45B. Abbott reaffirmed guidance for 7.5-8.0% organic growth. Eli Lilly (LLY) posted 54% revenue growth driven by Mounjaro ($6.52B) and Zepbound ($3.57B). Lilly raised guidance to $63.0-63.5B revenue. Lilly’s operating margin reached 48.3% versus Abbott’s 19.4%. Lilly trades at 49.5x P/E […]
Should I scoop up some Magnum Ice Cream shares for my ISA?
Shares of The Magnum Ice Cream Company (LSE:MICC) started trading today (8 December), making them eligible for an ISA portfolio. This came after the ice cream business was demerged from Unilever over the weekend. Unilever shareholders will receive one Magnum share for every five Unilever shares they own. However, I’m not a Unilever shareholder. So, […]
Protein, Exercise Can Curb Muscle Loss Related to GLP-1 RAs
Regular exercise and sufficient protein intake can help maintain muscle and preserve long-term health in patients taking GLP-1 receptor agonists. Medscape News Canada
Magnum ice cream valued at US$9.2bil in Amsterdam listing
Magnum, which will command more than a fifth of the US$87 billion global ice cream market, is betting on the allure of indulgent snacks. (EPA Images pic) LONDON: Magnum Ice Cream Company traded at €12.96 per share in its Amsterdam debut today, implying a market capitalisation of €7.93 billion (US$9.24 billion), as it finalised a […]
Wave Life Sciences says its RNA obesity shot cuts fat but retains muscle
Wave Life Sciences’ obesity therapy helped patients lose more fat mass and retain more muscle than low doses of Novo Nordisk’s Wegovy or Eli Lilly’s muscle-sparing candidate bimagrumab when compared across different clinical trials. …
STAT+: Driven by GLP-1s, prescription drug spending explodes at major health insurers
Health insurance companies have lamented fast-rising medical expenses for more than two years. This year is no different as Americans continue to get more care than insurers expected. One of the main culprits of that higher spending: prescription drugs, and GLP-1s in particular. Some insurers spent more on drugs in the first nine months of […]
Jim Cramer Prefers Buying Eli Lilly When People Are “Getting Antsy”
Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer discussed, along with the tech battleground. A caller asked Cramer about an optimal entry point into the stock, and he replied: “I think that people now are getting antsy and thinking that it’s really breaking down. That’s probably when I want to start […]